ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2075

CCR6+ Foxp3+ Regulatory T Cells Regulate the Development of Collagen Induced Arthritis in T Cell Specific RORγt Transgenic Mice

Yuya Kondo1, Masahiro Tahara1, Mana Iizuka1, Hiroto Tsuboi1, Satoru Takahashi2, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Anatomy and Embryology, Faculty of Medicine,, University of Tsukuba, Tsukuba, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: animal models and transcription factor, chemokines, Regulatory cells, rheumatoid arthritis, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Recent studies reported that IL-17 producing Th-17 cells appear to play an important role in the generation of several autoimmune arthritis models. We previously reported that T-bet expression regulates the development of collagen induced arthritis by suppression of antigen reactive Th17 cells differentiation via the repression of RORγt expression (Kondo Y et al. Arthritis Rheum 64,162-72, 2012). This observation suggested that RORγt might be pivotal on the development of autoimmune arthritis. The aim of this study is to clarify the effect of RORγt expression on T cells in the development of autoimmune arthritis.

Methods:

 1) Incidence and severity of collagen induced arthritis (CIA) were assessed in C57BL/6 (B6) and T cell specific RORγt transgenic (RORγt Tg) mice under the control of CD2 promoter. 2) Histological assessment of inflamed joints was performed with hematoxilin-eosin staining. 3) Collagen type II (CII) specific antibody in sera was measured with ELISA. 4) Draining lymph node cells were harvested from B6 and RORγt Tg mice at 10 days after the immunization of CII, and cultured in the medium containing CII. Cytokine level in supernatants were analyzed by ELISA. 5) Draining lymph node cells were cultured in vitro as described in 4), transcription factors expression on CD4+T cells was analyzed by FACS and real-time PCR. 6) The correlation between the expression of transcription factors and chemokine receptor 6 (CCR6) was analyzed by FACS.

Results:

1) CIA was significantly suppressed in RORγt Tg mice compared with B6 mice. 2) Histological assessments revealed that inflammation and bone destruction were milder in RORγt Tg mice than B6 mice. 3) Anti-CII antibody was significantly lower in RORγt Tg mice than B6 mice (P < 0.05). 4) IL-17 level in supernatant was significantly increased in RORγt Tg mice compared with B6 mice (P < 0.05). 5) FACS analysis showed that RORγt expression on CD4+ T cells was significantly higher in RORγt Tg mice than B6 mice. Although there was no significant difference of Foxp3 expression on CD4+ T cells between B6 mice and RORγt Tg mice, most of Foxp3+ CD4+ T cells also expressed RORγt in RORγt Tg mice. Bcl-6 expression on CD4+ T cells of RORγt Tg mice was comparable to that of B6 mice. 6) The expression of CCR6 on CD4+ T cells was significantly higher in RORγt Tg mice compared with B6 mice (P < 0.01). In particular, CCR6 was remarkably upregulated in Foxp3+ CD4+ T cells of RORγt Tg mice compared with that of B6 mice (P< 0.01).

Conclusion:

CIA was significantly suppressed in RORγt Tg mice, although IL-17 production from CII reactive T cells was increased. The inhibition of arthritis might be related with the increase in CCR6+ Foxp3+ CD4+ T cells in RORγt Tg mice.


Disclosure:

Y. Kondo,
None;

M. Tahara,
None;

M. Iizuka,
None;

H. Tsuboi,
None;

S. Takahashi,
None;

I. Matsumoto,
None;

T. Sumida,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ccr6-foxp3-regulatory-t-cells-regulate-the-development-of-collagen-induced-arthritis-in-t-cell-specific-ror%ce%b3t-transgenic-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology